GENEVA, May 5 -- ASTRAZENECA AB (SE-151-85 Sodertalje) filed a patent application (PCT/IB2024/060532) for "CRYSTALLINE FORMS OF TEAD INHIBITOR" on Oct 25, 2024. With publication no. WO/2025/088571, the details related to the patent application was published on May 01, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WU, Dedong (AstraZeneca Pharmaceuticals LP35 Gatehouse DriveWaltham, Massachusetts 02451), YANG, Wenzhan (AstraZeneca Pharmaceuticals LP35 Gatehouse DriveWaltham, Massachusetts 02451), MARDEN, Stacey Katherine (AstraZeneca Pharmaceuticals LP35 Gatehouse DriveWaltham, Massachusetts...